Pricing Log in Create free account

Monopar Therapeutics Inc. (MNPR) vs PureTech Health PLC Sponsored ADR (PRTCY)

Monopar Therapeutics Inc. and PureTech Health PLC Sponsored ADR are both Biotechnology companies. Monopar Therapeutics Inc. is the larger, with a market value of $469.1M against $424.0M — 1.1× the size. Monopar Therapeutics Inc. has the higher net margin (0.00% vs −199.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, PureTech Health PLC Sponsored ADR leads on 5 and Monopar Therapeutics Inc. on 3.

Valuation

Metric MNPR PRTCY Biotechnology median
P/E n/m n/m 10.64
P/S n/m n/m 9.59
P/B 4.55 n/m 2.15
Price to free cash flow n/m n/m 26.07
EV/EBITDA n/m 0.81 0.65
EV/Sales n/m (9.10) 9.45
Earnings yield (3.11%) (1.32%) (34.69%)
Free cash flow yield (2.05%) 0.00% (24.02%)

Profitability

Metric MNPR PRTCY Biotechnology median
Gross margin — 0.00% 65.59%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (199.36%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (19.50%) 0.00% (51.96%)
Return on assets (18.90%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MNPR PRTCY Biotechnology median
Revenue growth (TTM) — 28.48% 4.59%
EPS growth (last fiscal year) 54.99% (318.75%) 29.88%
Revenue growth, 5-year CAGR — (16.92%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MNPR PRTCY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 33.56 6.59 4.86
Net debt to EBITDA 8.06 3.03 1.01

Dividend

Metric MNPR PRTCY Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric MNPR PRTCY Biotechnology median
Market cap 469.11m 424.00m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack